Book of Medical Disorders in Pregnancy - Tintash
Book of Medical Disorders in Pregnancy - Tintash
Book of Medical Disorders in Pregnancy - Tintash
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
the efficiency <strong>of</strong> this immune globul<strong>in</strong><br />
<strong>in</strong>cluded limited follow up period <strong>of</strong> 72<br />
hours only.<br />
Prognosis:<br />
Toxic levels <strong>of</strong> bilirub<strong>in</strong> can cause<br />
damage when it passes from the serum<br />
<strong>in</strong>to the basal ganglion cells <strong>of</strong> the bra<strong>in</strong>.<br />
Neurosensory hear<strong>in</strong>g loss is the most<br />
common sequela <strong>of</strong> excessive serum<br />
bilirub<strong>in</strong>. Kernicterus is a cl<strong>in</strong>ical<br />
syndrome where deposition <strong>of</strong> unconjugated<br />
bilirub<strong>in</strong> <strong>in</strong> certa<strong>in</strong> nuclei <strong>of</strong> the<br />
bra<strong>in</strong>, affects central nervous system.<br />
The album<strong>in</strong> b<strong>in</strong>d<strong>in</strong>g capacity is decreased<br />
<strong>in</strong> conditions where there is<br />
acidosis or history <strong>of</strong> Sulpho amide adm<strong>in</strong>istration<br />
and or where free fatty acid<br />
levels are elevated.<br />
These conditions predispose the neonate<br />
to Kernicterus even with lower levels <strong>of</strong><br />
bilirub<strong>in</strong>.<br />
The baby, who develops kernicterus,<br />
suddenly becomes lethargic and stops feed<strong>in</strong>g.<br />
His cry becomes high pitched. The<br />
respiratory rate becomes slow. Apnea,<br />
respiratory, arrest, and even convulsions<br />
may occur <strong>in</strong> severe cases. Infants who<br />
survive, have severe motor impairment,<br />
<strong>in</strong>clud<strong>in</strong>g hypotonia, spasticity, and<br />
athetosis.<br />
Mental retardation may occur but it is<br />
generally less severe. In term<strong>in</strong>al stages,<br />
the babies have irregular gasp<strong>in</strong>g<br />
respirations, bloody discharge from the<br />
nose and mouth. Most babies die with<strong>in</strong><br />
48 to 72 hours.<br />
Mortality or morbidity: Unlike<br />
unconjugated bilirub<strong>in</strong>, conjugated<br />
134<br />
bilirub<strong>in</strong> does not b<strong>in</strong>d significantly to<br />
neural tissue and does not lead to<br />
kernicterus or other forms <strong>of</strong> toxicity.<br />
• The morbidity and mortality associated<br />
with conjugated hyperbilirub<strong>in</strong>emia<br />
result from the under-ly<strong>in</strong>g<br />
disease process.<br />
In certa<strong>in</strong> disease states, such as<br />
alcoholic hepatitis or primary biliary<br />
cirrhosis, bilirub<strong>in</strong> levels correlate<br />
strongly with, but do not contribute to,<br />
short term mortality.<br />
The Group "0" rhesus negative packed<br />
cells should be cross mulched and found<br />
compatible with mother's blood. The<br />
hemoglob<strong>in</strong> <strong>in</strong> these cells should be<br />
around 26 to 28 gram per 100 ml and<br />
hematocrit <strong>of</strong> 85 to 95 per cent.<br />
The second transfusion could be given<br />
after 10 days and the 3rd and 4th with<strong>in</strong><br />
3 to 4 weeks <strong>in</strong>terval from the second.<br />
Delivery should be conducted around 34<br />
to 35 weeks.<br />
If on x-ray hydropic fetus with<br />
ascites is found then ascitic fluid is<br />
withdrawn first and mother is given<br />
digitalis and diuretic.<br />
Risks <strong>of</strong> <strong>in</strong>trauter<strong>in</strong>e transfusion:<br />
Only 45% <strong>of</strong> <strong>in</strong>trauter<strong>in</strong>e transfused<br />
babies are born alive and one third<br />
actually survive.<br />
The risk <strong>of</strong> immediate death after first<br />
<strong>in</strong>trauter<strong>in</strong>e transfusion is around 10 to<br />
12 per cent and another extra 5 per cent<br />
with each successive transfusion. The<br />
overall risk is around 7 per cent.<br />
Neonatal death rate <strong>in</strong> these babies is<br />
around 8 per cent.